DK166878C - Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser - Google Patents

Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser

Info

Publication number
DK166878C
DK166878C DK320585A DK320585A DK166878C DK 166878 C DK166878 C DK 166878C DK 320585 A DK320585 A DK 320585A DK 320585 A DK320585 A DK 320585A DK 166878 C DK166878 C DK 166878C
Authority
DK
Denmark
Prior art keywords
fluorallylamines
compounds
acid addition
addition salts
pharmacologically acceptable
Prior art date
Application number
DK320585A
Other languages
English (en)
Other versions
DK320585A (da
DK320585D0 (da
DK166878B (da
Inventor
Ian Alexander Mcdonald
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK320585D0 publication Critical patent/DK320585D0/da
Publication of DK320585A publication Critical patent/DK320585A/da
Publication of DK166878B publication Critical patent/DK166878B/da
Application granted granted Critical
Publication of DK166878C publication Critical patent/DK166878C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/42—Halogenated unsaturated alcohols acyclic
    • C07C33/423—Halogenated unsaturated alcohols acyclic containing only double bonds as unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
DK320585A 1984-07-13 1985-07-12 Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser DK166878C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63055684A 1984-07-13 1984-07-13
US63055684 1984-07-13

Publications (4)

Publication Number Publication Date
DK320585D0 DK320585D0 (da) 1985-07-12
DK320585A DK320585A (da) 1986-01-14
DK166878B DK166878B (da) 1993-07-26
DK166878C true DK166878C (da) 1993-12-13

Family

ID=24527644

Family Applications (1)

Application Number Title Priority Date Filing Date
DK320585A DK166878C (da) 1984-07-13 1985-07-12 Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser

Country Status (20)

Country Link
EP (1) EP0168013B1 (da)
JP (1) JPS61257952A (da)
KR (1) KR900008113B1 (da)
AR (1) AR240043A1 (da)
AT (1) ATE32711T1 (da)
AU (1) AU575973B2 (da)
CA (1) CA1256453A (da)
DE (1) DE3561723D1 (da)
DK (1) DK166878C (da)
ES (1) ES545111A0 (da)
FI (1) FI84057C (da)
GB (1) GB2162518B (da)
HU (1) HU195181B (da)
IE (1) IE58305B1 (da)
IL (1) IL75739A (da)
NO (1) NO161313C (da)
NZ (1) NZ212675A (da)
PH (1) PH21647A (da)
PT (1) PT80805B (da)
ZA (1) ZA855101B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2033233T3 (es) * 1985-12-05 1993-03-16 Merrell Dow Pharmaceuticals Inc. Un procedimiento para preparar una fluoralilamina.
EP0283168A3 (en) * 1987-03-16 1989-06-14 American Home Products Corporation Fluorooxirane carboxylates
US4822812A (en) * 1987-05-21 1989-04-18 Merrell Dow Pharmaceuticals Inc. β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
US20070293548A1 (en) * 2006-03-31 2007-12-20 Wang Eric Y Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases
SG11201406948PA (en) 2012-05-02 2014-11-27 Boehringer Ingelheim Int Substituted 3-haloallylamine inhibitors of ssao and uses thereof
WO2024044813A1 (en) * 2022-08-29 2024-03-07 Pharmaxis Ltd. Novel selective inhibitors of lysyl oxidases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1027611A (en) * 1962-01-04 1966-04-27 May & Baker Ltd Phenoxy- and phenylthio-alkylamines and acid addition salts thereof
US3205136A (en) * 1962-12-24 1965-09-07 Smith Kline French Lab Antidepressant phenyloxyalkylamines
US3513198A (en) * 1965-10-22 1970-05-19 Hoffmann La Roche Aryloxy- and arylthio-acetylenic amines and the salts thereof
CH485681A (de) * 1966-06-03 1970-02-15 Ciba Geigy Verfahren zur Herstellung von schwefelhaltigen Aminen

Also Published As

Publication number Publication date
CA1256453A (en) 1989-06-27
GB2162518B (en) 1987-11-18
GB2162518A (en) 1986-02-05
DK320585A (da) 1986-01-14
FI84057B (fi) 1991-06-28
FI84057C (fi) 1991-10-10
PT80805A (en) 1985-08-01
FI852748A0 (fi) 1985-07-11
NO852810L (no) 1986-01-14
JPH0530823B2 (da) 1993-05-11
IL75739A (en) 1988-07-31
ES8603809A1 (es) 1986-01-01
PT80805B (pt) 1987-09-18
AU4466085A (en) 1986-01-16
EP0168013B1 (en) 1988-03-02
HUT38604A (en) 1986-06-30
IE58305B1 (en) 1993-09-08
PH21647A (en) 1988-01-13
ATE32711T1 (de) 1988-03-15
DE3561723D1 (de) 1988-04-07
NO161313B (no) 1989-04-24
IE851746L (en) 1986-01-13
ZA855101B (en) 1986-05-28
ES545111A0 (es) 1986-01-01
JPS61257952A (ja) 1986-11-15
KR900008113B1 (ko) 1990-10-31
DK320585D0 (da) 1985-07-12
FI852748L (fi) 1986-01-14
IL75739A0 (en) 1985-11-29
NZ212675A (en) 1988-02-29
AR240043A1 (es) 1990-01-31
AU575973B2 (en) 1988-08-11
NO161313C (no) 1989-08-02
GB8517454D0 (en) 1985-08-14
HU195181B (en) 1988-04-28
DK166878B (da) 1993-07-26
KR860001048A (ko) 1986-02-22
EP0168013A1 (en) 1986-01-15

Similar Documents

Publication Publication Date Title
DK108388A (da) Piperazinylalkylheterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK359986D0 (da) Phenylethere, fremgangsmaader til fremstilling samt farmaceutiske midler indeholdende disse
DK165693C (da) 2-(n-substitueret guanidino)-4-heteroarylthiazol-forbindelser og farmaceutiske praeparater indeholdende disse
DK157931C (da) 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridinderivater og terapeutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende disse
DK346486D0 (da) Aminosalicylsyrederivater og farmaceutiske midler
DK162986C (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater indeholdende disse
DK164594C (da) 1,4-dihydro-pyridin-3,5-yl-dicarboxylsyrederivater, farmaceutiske praeparater indeholdende disse derivater samt fremgangsmaade til fremstilling deraf
DK259186A (da) Nasale farmaceutiske praeparater
DK126888D0 (da) Bisphosphonsyrederivater og terapeutiske praeparater indeholdende disse forbindelser
DK163990C (da) Oxindol-3-carboxamid-derivater og farmaceutiske praeparater indeholdende disse
DK158357C (da) 9-deoxo-9a-(ethyl eller n-propyl)-9a-aza-9a-homoerythromycin a og farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende disse forbindelser
DK166878C (da) Fluorallylaminer og pharmakologisk acceptable syreadditionssalte deraf samt pharmaceutisk praeparat indeholdende disse forbindelser
DK78888A (da) Arylpiperazinylalkylenphenyl-heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK162600C (da) Oe4-(2-hydroxycyklohexylmethyl)phenylaaalkansyrederivater og fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK52086A (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK314386D0 (da) Quinoloncarboxyylsyreforbindelse og antibakterielle farmaceutiske praeparater indeholdende denne
DK307085D0 (da) 4-phenyl-2-trifluormethyl-1,3-dioxan-5-ylheptensyrederivater, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
DK712388D0 (da) Heterocyclisk substituerede oxo- eller thiophthalazinyl-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse
DK21785A (da) Dihydropyridinforbindelser og farmaceutiske praeparater indeholdende disse
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK81185A (da) Carboxicam-enolester-forbindelser og farmaceutiske praeparater indeholdende disse
DK4487A (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
DK35889D0 (da) Vitamin d3 derivater og farmaceutiske praeparater indeholdende disse forbindelser
DK344384D0 (da) 2-heterocyclylalkylthio-6-(alfa-hydroxyethyl)-2-penem-3-carboxylsyre-forbindelser og farmaceutiske praeparater indeholdende disse
DK160299C (da) Basiske 2-fenylenmetylen-cykloalkanoximaetere eller farmaceutisk acceptable syreadditionssalte deraf samt farmaceutiske praeparater indeholdende saadanne forbindelser